>> it's true that the one combination that worked the best after johnson & johnson was getting a johnson & johnson, then followed by moderna or pfizer. that was just antibody data from the nih. but, the study today really nailed it, sweetest study that looked at -- swedish study that looked at johnson & johnson dna for astrazeneca, and followed by mrna vaccine in a clinically protected you more. so, yes, i do think as a clinician i will make recommendation after johnson & johnson for an mrna vaccine, and it will make the second shot of johnson & johnson not as appealing. >> general colin powell's passing yesterday had vaccine hesitant folks again asking, isn't that proof that the vaccine doesn't work. before you answer, i should point out that his wife was also fully vaccinated, was infected with covid, vet has been treated and has been sent home. can you analyze their situations and tell us what you think they actually show about vaccine effectiveness? >> the vaccines work really well. i am sorry for his passing, but what happened here is that he was being treated for multiple myeloma,

johnson one-shot vaccine. they were unanimous. but one of the key questions in that room, should the johns johnson & johnson vaccine have been a two-dose vaccine a night long? the country moves forward with boosters for each of the vaccines. and today on the johnson & johnson shot, members of the panel saying the second dose, the booster, important because while the first dose effective, not as strong as they'd hoped. saying there's real urgency to their decision today. >>> the other headline involves tourism, visitors to the u.s. the u.s. announcing foreign visitors who are fully welcome will be welcome beginning november 8th, about three weeks from now. we begin with the new booster it will panel saying yes, and abc's whit johnson leading us off. . tonight a fda advisory panel -- but unlike pfizer and moderna boosters limited to older adults or those at high risk, the panel recommending the j&j for anyone 18 and older at least two months after getting the first vaccine. >> the fda panel recognized serious urgency to support patients that have gotten the j&j vaccine, but ultimately we're not necessarily satisfied with all the options

, and it's an fda panel, and they will be talking about boosters for johnson & johnson, whether it, and it will likely be the johnson & johnson vaccine as a booster, but there is quite a bit of data, and again, some of the data is a little bit flawed , like study size, for example, where you could receive an mrna vaccine, a pfizer or moderna brand, after johnson & johnson as a booster. that will also be discussed tomorrow, but highly likely that johnson & johnson will also receive, through that same brand, a booster recommendation. in within the next week or so, it'll be approved by the fda, then started, we have already started the planning process weeks ago when we heard about pfizer to get ready for moderna and johnson & johnson. >> i was going to ask you. is the bay area ready? a lot of us look back to what it was when we initially were getting vaccines. they were in short supply. it was hard to get an appointment. do you anticipate those problems with these boosters? >> not at all. we've been so fortunate since about the middle of may to receive adequate and consistent vaccine supplies, of all three brands. ver

johnson&johnson. dio luz verde para combinar esta dosis. mÁs de 1500 millones de personas se vacunaron con moderna y casi 13 millones con johnson&johnson. —— ar coronavirus. la pregunta es cÓmo una persona que nos estÉ viendo ahora mismo en la ediciÓn digital va a saber quÉ vacuna ponerse como tercera dosis. doctor juan: gracias por la pregunta, creo que lo mÁs importante es que cada uno hable con su doctor, esto quizÁs no es tan importante para personas que se pusieron la pfizer o personas que se pusieron la de moderna, sino quizÁs es mÁs importante para personas que se pusieron la de johnson&johnson, porque sabemos que la efectividad de la vacuna de johnson&johnson es un poco menos efectiva que la de pfizer o la de moderna. si usted es una de esas personas, combinarla con un refuerzo de moderna, o con un refuerzo de pfizer puede resultar en una efectividad mÁs alta, que sÓlo tener una dosis de johnson&johnson. ojo, y johnson&johnson, como bien lo decÍan, tambiÉn acaba de reportar que en su refuerzo que se pone luego de dos meses de la primera dosis tambiÉn se brinda una protecciÓn significativa. en estados unidos no creo que haya escasez

& johnson and the recommendation at the end of next week is, yeah, we think johnson & johnsonl shot, go with that, because it's going to take a while for them to sort out what should johnson & johnson folks get eventually. should they be mixing and matching? should they get a pfizer or moderna shot? as you alluded, ana what, this small study found of about 450 people what, it found was that folks who got johnson & johnson were better off getting a moderna or pfizer booster. they did better if they got a moderna or pfizer booster than if they got a j&j booster but it's a relatively small study. the booster with j&j still did quite well so you're not hurting yourself by going out there and getting a johnson & johnson booster. you always want to do things in a timely way. go ahead with what they say and then we can lack at the other stuff later. >> let head to connecticut and president biden. >> i know that a lot of people are in desperate need of a facility like this in child care. i didn't really appreciate it as a young member of the county council when i was 27 years old, but

& johnson at folks guy johnson and johnson dose. can they get a second johnson or the single johnson & johnson and then one of the two mrna vaccines, but theoretically if you got a pfizer or moderna originally you can then turn around and get one of the other ones. pfizer for your first two jabs get the madarna booster or vice versa that study that the fda panel looked at today did come to the conclusion that mits and imagining the vaccines leads to similar immune. responses, so some really interesting facts there to consider going forward. yeah, really very interesting. okay tim. thanks very much. bart employees will be required to get fully vaccinated. the new policy goes into effect in mid-december, but what's unclear is whether there will be a testing option and what will happen to those who refuse to get the shots abc 7 news reporter laura anthony has a closer look at the decision. bard is now going the way of many other public agencies and private companies with a decision to require its nearly 4,000 employees to get vaccinated

johnson one-shot vaccine. they were unanimous. but one of the key questions in that room -- should the johnson & johnson vaccine have been a two-dose vaccine all along? tonight, it appears the country is moving forward with boosters for each of the vaccines. and today on the johnson & membs t paye nd sethooer, is imptarsile e, wass real urgency to their decision today. >>> the other major headline tonight involves tourism in the u.s., visitors to the u.s., another encouraging sign we're moving forward. the u.s. announcing foreign visitors who are fully vaccinated will be welcome beginning november 8th. about three weeks from now. we begin with the new booster. the panel saying yes, and abc's whit johnson leading us off. >> reporter: tonight, a fda advisory panel voting anonymously to approve booster shots. but unlike pfizer and moderna boosters limited to older adults or those at high risk, the panel recommending the j&j booster for anyone 18 and older at least two months after getting the first single-shot vaccine. >> the fda panel clearly recognized some serious urgency to support the patients that have gotten the j&j vaccine, bu

way too high for my liking, so i would say that anybody who got johnson & johnson should absolutely get a booster two months later with johnsono your point, i think it is worth talking to your health professional about your circumstance and decide whether it makes sense for you to get an mrna shot. so, at a minimum, everyone who got johnson & johnson needs something. at least two months, second dose, that's exactly what the fda advisory committee weighed in on. two months. or to have that conversation about which you might prefer in terms of an mrna vaccine. i've had some patients where i have said, i think you should get an mrna vaccine. and we have a full approval for pfizer, so there's some flexibility to do that. and i think that's where individual conversation needs to take place. but johnson & johnson, you need to get something. the efficacy rates were not high enough to feel like you can be protected months out. >> last question here, real quick. remember when johnson & johnson was first released, it was then subsequently paused for about ten days because this very rare side effect of blood clotting in individuals. is

johnson is a little bit different. there's no age restriction or underlying health condition restriction. everybody that got johnson & johnson -- it is approved. -- approved for 18 years old and older. they can get a second dose of johnson & johnson or another covid vaccine. governor newsom got the moderna as a booster. >> they can do it after just two months from their original shot. governor newsom is saying it is absolutely safe and perhaps even great to mix-and-match, which is what he did. >> yet. a lot of research has been done -- >> yet, a lot of europe has been done in europe -- >> yeah, a lot of research has been done in europe with the mrna vaccine. data points out that mixing with moderna or pfizer increases the efficacy and the potency of the vaccination. that is the information the fda and cdc took into make the recommendation of mixing doses. >> i want to make the point that for the booster, people don't have to go where they originally went to get their shots. wherever they can get an appointment is fine. i want to ask you, there are folks who have questions, if you received the original shots without any side

johnson & johnson. "queremos proveer una protecciÓn Óptima y sabemos que una dosis de refuerzo lograrÁ este objetivo" dijo esta portavoz de la johnsonncionar mejor, si la gente esperara hasta seis meses despuÉs en lugar de dos meses como se habÍa planteado. el grupo de asesores voto a favor de que se aplique una dosis de refuerzo. se citÓ la evidencia de que los receptores de johnson & johnson son mÁs favorables a la infecciÓn que aquellos que recibieron pfizer o moderna. >> es suficiente para prevenir las fidelizaciÓn o muerte, pero el nivel de eficiencia era mÁs bajo porque no tenÍan la segunda dosis. reportera: entre los que se vacunarÁn con la johnson hay espectativas. >> y yo me aplique la primera dosis de johnson y me parece importante. reportera: expertos analizaron hoy los datos preliminares de un estudio gubernamental que sugiere que los que recibieron la johnson & johnson pueden tener una respuesta inmunitaria mÁs fuerte si reciben una segunda dosis de pfizer o de moderna en vez de la de johnson & johnson. la decisiÓn podrÍa ser afirmativo. >> hay teorÍa que demuestra que sin duda, cuando se mezclan, salen resultados muy b

out and saying you can preferentially get a moderna user if you got johnson & johnson, for the 50 million americans who got the johnson & johnson shot the first time it needs to get whatever is available to them if they are high-risk. and we know that people who already got vaccinated, from the data we have seen from june on, you are still very well protected against hospitalization or death. kristen: you said worldwide so that will help me pay that, the u.s. is loosening travel restrictions by opening its land borders with canada and mexico to fully vaccinated foreign travelers. do you think this signals a new phase in our pandemic management? -- ? dr. patel: i do because in the early days, part of the reason the pandemic was spreading is because of open borders and people were focusing on closing the board from china, the delta variant does not care what borders are closing, it will spread as quickly as it can and diseases are one flight away. anyone looking at vaccine restrictions saying oh my gosh, this is control, think about any time you have flown to other countries, especially sub-saharan africa or asia, you n

johnson vaccine. that has to be considered. the johnson & johnson vaccine in two doses gives you a different type of immune response. putting all of that together in the phase one and phase two data, the johnson & johnson vaccine as a two dose vaccine is still very good. >> how comfortable -- i know that pfizer, moderna, johnson & johnson have good scientific reputations. that said, how comfortable are you that we are relying on their data sets, their collection of data? shouldn't this be done independently? shouldn't we be asking maybe it's another academic institution, but shouldn't we collect the data on the vaccines that way? >> typically it would be a combination of the two. there would be independent studies. this is why pfizer had the advantage of the data collected by the ministry of health of israel and israeli scientists. same with the uk. you are right. this has been a problem that we have had with cdc that we have not really collected vaccine effectiveness data here in the u.s. at the level we should have. that's working to the disadvant

johnson & johnson booster and also looks at this notion of mixing and matching vaccines, whether that might be effective? >> reporter: david, that panel will then vote on whether the data is strong enough to authorize the johnson johnson booster shots, but this discussion of mixing and matches vaccines and whether it's effective will also be getting a lot of attention. right now, there is not a vote scheduled on that, but the early data is promising. it's a big debate. and we expect to hear a lot more in the coming days. david? >>. >> all right, whit johnson leading us off tonight. whit, thank you. i know many questions at home with millions of americans who got moderna and johnson & johnson still waiting on these boosters. let's get right to dr. ashish jha, dean of the brown university school of public health. always great to have you here. seems this blueprint for the moderna boosters very similar to what we saw with the pfizer boosters. 65 and older first, along with 18 and older if you have a health condition or a job that puts you at higher risk. one thing i thought was interesting, moderna's booster will be given as a half dose, 50 micrograma, that a will be given as a half dose, 50 micrograma, tha micro

& johnson pero hay confusión, vamos con los detalles con lourdes hurtado que tiene la informión de los expertos. >> quienes eligieron johnson & johnsonena alternativa al ser una sola dosis. >> pero hoy el panel de la administración general de alimentos y medicinas recomendó una dosis de refuerzo de l vacuna contra el covid-19 para todos los mayores de 18 años vacunados con johnson & johnson después de dos mesese la primera dosis. >> ahora el problema es saber cuál elegir porque dicen que mezclar y combinar la dosis de moderna y pfizer daría mejor protección. >> lo recomendable para quienes tienen vacuna de johnson & johnson es vacunarse con una vacuna que tiene mrna porque los anticuerpos suben. >> esto provoca confusión. >> te pondrías la vacuna de refuerzo >> sí y si fuera de la misma marca. >> ahora para los que reciben johnson & johnson pueden escoger un refuerzo de moderna y pfizer. >> las recomendaciones del gobierno van un poco atrás de la ciencia y no me extraña y sí anticipo que en breve vamos a ver que las recomendaciones que todo el mundo se vacune con una tercera dosis de las vacunas >> la urgencia es lograr que los que f

johnson & johnson vaccine to receive a booster shot from the moderna vaccine or pfizer vaccine. >> in the real world all of this is ready g, tter of urgency. >> reporter: a study found people with the johnson & johnson vaccine were better off getting a booster from moderna vaccine or pfizer vaccine. >> we do not know whlong- term effects will be. we just do not have the data. >>> looking live at san francisco international airport, visitors from outside the united states have a new date to circle on their calendar but only if they are vaccinated. >> reporter: they will lift covid-19 travel restrictions november 8 if they are fully vaccinated . the international terminal here at san francisco international airport is quiet and millions of visitors were not allowed into the united states over the course of the pandemic . foreign travelers will have to show proof of vaccination before they board the plane. this allows for all authorized vaccines or vaccines the world health organization has approved for emergency use. they will also have to show a negative covid-19 test withiner . the white house is required not lifting restrictions at this time for unvaccinated travelers. a spokesperson said

recomendaciones. >>> muchas personas ahora se preguntan que si se vacunaron con johnson & johnson deben vacunarse con johnsonlicaron un estudio y compararon los resultado de recibir vacuna de johnson & johnson pero expertos señalan que son resultados significativos pero dice este panel que si tienen dudas, es mejor consularlo con un experto. >>> muchas gracias , buen día . >>> y el ex presidente bill clinton mejora en un hospital de lifornia y esto tras sentirse indispuesto durante un evento . >>> buenas tardes, la información es que la condicion del ex presidente han mejorado en las últimas horas y el ex mandatario estaba acá en el sur de california para asistir a un evento de su fundación cuando comunicó a miembros de su equipo que no es sentía bien entonces fue llevado al hospital irvign y ahí entonces se le puso un tratamiento de manera intravenosa pero el presidente ha respondido bastante bien y los médicos dicen que pudiera ser dado de alta hoy o mañana y su esposa voló ayer para asistir a este evento de su esposo y luego vino al hospital para saber que todo estaba bien, y fue con su cardiólogo y todo

johnson? when they first released the johnson & johnson vaccine, they also came out with this rare side effect as we all remember, and hence, johnson & johnson was subsequently paused for about a ten-day period as they reviewed this rare side effect of blood clots among individuals. if you were someone who received johnson & johnson and are anticipating getting a booster shot, is there any science pointing to this rare side effect once again being a complication with this booster shot? >> yeah, thank you for raising that. one of the most common i guess pushbacks or concerns that i hear from people who are labeled as anti-vaxers but it includes a lot of my own patients. i serve a lot of underserved population of new york city and new york state, it's side effects. they say i heard the vaccine is more dangerous than the disease and the virus. i can get clots. it can affect my heart. so it's really important to communicate to the public and to the viewers and including my own patients, that the side effects that have been noticed, some of these rare clotting disorder, rare events of clots are jus

johnson vaccine. for women under age 50, which is the category i am in, i would not recommend that they get a second johnson & johnsoner. i would recommend that they receive one of the pfizer or moderna vaccines, one of the mrna doses because the johnson & johnson vaccine has been associated with a very rare but very serious blood clotting disorder. this is not a run of the mill blood clot. this is a serious dsorder that can be fatal. again, very rare, but for younger women, there is an tion, another option of pfizer or moderna that is not associated with this particular side effect and, so, for those individuals, i would definitely recommend a second mrna dose instead of the j&j booster. i should also recommend the f.d.a. and c.d.c. are essentially saying though they haven't explicitly said this, but are essentially forecasting the j&j vaccine should have been a two-dose vaccine from the start. unlike pfizer-moderna where only individuals in a high risk category should be getting a booster six months after their first two doses, for the johnson & johnson vaccine, anyone after two months, regardless of risk, should b

johnson & johnson had one at 72% versus moderna and sizer, 94 and 95%. now, to understand that, with a booster, johnson100% with efficacy. now, that's pretty impressive. and if that's the case, you know, many people are kind of wondering why didn't they just use two dose from the beginning. >> that's such a great question, fred. and one of the reasons is that, you know, the bar for vaccinations is at least over 50% for the fda. so, in the single dose formation, they reached 72% efficacy. when we look at the data submitted to the fda and the briefing documents for moderna and pfizer, with one dose they reached about 35 to 45%. it was the second dose that got them to 94 or 95%. so it's the same two-dose regiment as moderna and pfizer. >> even though one dose is appealing to a lot of people, even though the efficacy rate is a little low, it does inspire more people who actually get vaccinated? >> no, absolutely. we certainly have groups that absolutely benefit from this johnson & johnson vaccine. and we want to have always remember that. and also, we want to know that it was 100% protected against death a

>>> la combinación de "johnson & johnson" con "moderna", otras vacunas la respuesta superior es que si combinan con "johnsonesto con las vacunas es algo seguro? >>> tenemos en este país vacunas muy efectivas, "johnson & johnson", "moderna", "pzifer", vacunas que han sido seguras, todas son muy seguras de vacunas que han disminuido la mortalidad, vemos que están de caídos que significa el agente está regresando, a diferencia de otros estados de diferentes vacunas >>> muchas graciaspor la información. >>> cambiando de información oficiales de la policía de alameda (inaudible) que están de no ahora, durante la investigación de se descubre que los delincuentes (inaudible) para clasificar la intensidad. esta droga está en las más tóxicas que la heroína y está siendo más que la morfina, yo aumenta el riesgo de una sobredosis accidental >>> hablemos de los estafadores que siempre están actualizando sus métodos para robar a las personas. si nos fijamos en una trampa la que utiliza como excusa (nombre extranjero) y las redes sociales, tenemos más de qué se trata este fraude cómo detectarlo >>> pasando la medianoche,

johnson & johnson vaccine look at boosters? >> this is very different. i'm one of the 15 million americans who got one dose johnsonnson vaccine for women under the age of 50 which is the category i am in, i would not recommend that they get a second johnson and johnson booster. i would recommend that they receive one of the pfizer or moderna vaccine, one of the mrna dosesecause the johnson and johnson has been associateed with a very rare but very serious blood clotting disorder. this is not a run of the mill blood clot. s that very serious disorder that can be fatal. again, very rare. but for younger women there is an option. there is another option of pfizer or moderna that is not associateed with this particular side effect. and so for those individual, i would definitely recommend a second mrna dose instead of the j & j booster. i should mention that the f.d.a. are essentially forecasting that the j & j vaccine should have been a two-dose vaccine from the start unlike pfizer and moderna where only individuals in a high-risk category should be getting a booster six month avs their first two dose, if for the joh

johnson & johnson vaccine have not been told that. i would hope what the fda does at the minimum is to harmonize to reduce confusion. they should at the minimum say that johnson & johnson recipients should be able to get a booster six months out. there's a question of maybe they should get a booster sooner. maybe also as elizabeth reported they should be able to receive a mix-and-match approach with pfizer or moderna. i hope that's also the case. at a baseline, they should be at least told first and second they could get a booster after that shot. >> i've heard doctors say for a while j&j should be considered a two-dose vaccine because of what is being seen in terms of waning immunity. what do you think of that? part of the j&j shot was the convenience factor for many. >> that's right. i still think that if i have a patient, for example, who i know is not going to get followthrough, they're not going to come back for a second dose of the vaccine, and they'll just get one vaccine, then i would still recommend the johnson & johnson vaccine to that person because one dose of j&j appears to be longer lasting to provide better protection than one dose of pfizer or

& johnson vaccine. >> i know, and you've told our viewers several advertitimes, y the johnson & johnson what are your intentions now? >> i'm glad, first of all, there's some kind of guidance for the 15 million americans who got the johnson & johnson vaccine. i was also heartened to hear today the advisory committee discuss the very exciting miss and match data, because i think there are a lot of people including myself who do not want to get a second dose of the j&j vaccine necessarily and who might want to have the option of a mix and match approach. what i plan on doing is to get an mrna second dose. and the reason is that the johnson & johnson vaccine has been associated, especially in women under 50, with a very rare but very severe blood clotting disorder. so it might be less safe than the mrna vaccine which has been found to be safe in combination with j&j. and the data shows at least a second dose of the mrna vaccine appears as effective if not more effective than the second dose of the j&j vaccine. i really hope the fda and cdc will come out with that recommendation. >> so do yo

johnson booster. jenee norman starts us off with the story. >> the fda advisory panel is backing the j&j booster shot for everyone 18 and johnson & johnson'sne dose has shown to be 85% effective against severe illness, add a second dose and it jumps to 100% effective against severe illness. this morning, the 15 million americans who got the johnson & johnson vaccine could soon be eligible for a booster shot. that decision now in the hands of the fda and the cdc. >> we do have 19 out of 19 unanimous "yes" votes for this question. >> reporter: this after the fda advisory panel voted unanimously to authorize the booster saying the shot could come roughly two months after the first single shot vaccine for everyone 18 and older. johnson & johnson saying in a statement that booster dose provided 94% protection against moderate to severe covid symptoms. devin gauffman got the johnson & johnson vaccine as soon as he was eligible and now he's eager to get a booster. >> as soon as it's ready, i'll be ready to get it. >> reporter: health experts on the fda vaccine panel are waiting for more data as they consider whether it's safe for johnson & johnso

johnson to bill itself a one-shot vaccine? >> well, you know if the mrna vaccines from pfizer and moderna had not been so utterly effective, then johnson & johnsonwith their one dose. their standards are being set awfully high here by the other vaccines and certainly the data discussed yesterday by fda's advisory committee says you get that second dose two months or more after the first one and you get a big boost in the antibody di levels and presumably, also a boost in your protection against severe disease. so i understand why they made the recommendation they did. >> and why is the johnson & johnson booster recommended for everyone as long as two months have passed, but the pfizer and moderna are still limited to certain americans? you have to be above the age of 65, have an underlying health condition or a job that puts you at high risk. why not just say, everybody go get a booster. >> good question. i have two grandchildren that got j&j and they're interested in this, too. i think what the advisory committee was saying maybe this should have really been a two-dose vaccine and since everybody got two doses of pfizer and moderna, maybe we ou

johnson & johnson covid vaccines for millions of americans hours after the biden admini children miguel almaguer now with the latest. >> reporter: authorized by the fda late today, booster shots for adults fully vaccinated with moderna and johnson & johnson could be days away the stage now set for the cdc's review after the fda also approved mixing and matching boosters >> done! >> reporter: it comes as the white house unveiled its massive plan to begin vaccinating 28 million children between the ages of 5 and 11 who could qualify for their first shot of pfizer's vaccine as soon as early november >> so the main idea of this -- >> reporter: the logistical roll-out using trusted sites like schools and community centers to ensure families have easy access to the free vaccines. >> why is vaccinating this age group so important?

johnson vaccines. this is only antibodies. there's more than one way to look, but antibodies are the easiest way. fire data has shown that johnson & johnson antibody levels are remarkably stable over time, whereas antibody levels after mrna vaccines, while they are hired to begin with, declined somewhat. unfortunately, there were no safety concerns in that smaller study. >> the wall street journal is reporting the fda is delaying and that decision on authorizing moderna's vaccine for children. the risk of a rare heart inflammatory addition, can you explain more about that and how concerned parents should be? >> there has been a small number of cases of heart muscle inflammation after mrna vaccinations muckalt myocarditis. mostly it is in young adult males, and essentially it results in a few days. it usually doesn't have any, doesn't require hospitalization for the most part. there have only been a few for it, and generally it resolves within a few days. because of this, the fda is probably taking extra care in vetting the data around giving moderna vaccines emergency use authorizations for adolescents, to make sure that it's okay. we don

johnson & johnson boosters, too. the panel also clearing the way for mixing and matching. and this question tonight -- if you got the one-shot johnson & johnson vaccine, should you consider a pfizer or moderna booster? dr. jha standing by to answer your questions tonight. >>> also developing late today, huse lawmakers including nine republicans voting to recommend criminal contempt charges against steve bannon for refusing to show up to answer questions about what led to the january 6th attack on the capitol. and the audio, what bannon told his listeners just one day before the attack. jon karl standing by. >>> also at this hour, the news just coming in tonight on queen elizabeth, spending the night in a hospital. we'll go live to london. >>> the americans kidnapped in haiti, held for days now. and tonight, the chilling threat from the gang leader. the video on social media. the demands. and why authorities are studying this video message. >>> authorities late today in california on three members of . their dog dying, too, and now we learn how they died. the findings revealed. >>> the storms in the west. several days of heavy rain,

johnson & johnson. la pregunta mÁs importante si debe recibir la vacuna de johnson & johnson o de rna, moderna, pfizer. serÍa mejor recibir una vacuna de pfizer o de moderna. borja: pero claro, escuchÁndote hablar, surge la personas pueden elegi entre cual vacuna ponerse como tercera dosis o existen recomendaciones especificas? q4. jovenes y carlos: que van a hacer es que recibas la siguiente vacuna a la que habÍas recibido inicialmente. paulina: doctor, los jÓvenes y los niÑos, ¿tambiÉn deberÁn recibir una tercera dosis en el futuro? carlos: no lo sabemos todavÍa porque no tenemos suficientes datos. en este momento la recomendaciÓn es para los mayores de 18 aÑos. paulina: muchÍsimas gracias por aclarar estas dudas, doctor carlos del rÍo, muchas gracias y muy buen dÍa. nosotros seguimos con mÁs noticias. la escuela privada de miami vuelve a estar en el centro de la controversia. estÁ diciendo que los estudiantes vacunados deben quedarse en casa 30 dÍas por cada dosis para proteger a los demÁs. hay que recordar que en abril causÓ revuelo la prohibiciÓn a los maestros para que interactÚen con los estudia

johnson & johnson not quite as high. but that johnson & johnson stays pretty constant, whereas pfizer and moderna dip down over a six to eight-month period. saying we need boosters for pfizer and moderna. talk about the boosters for johnson & johnson. do we need them as well? the answer is? e. voted unanimously mainly because we thant would bring that constant rate we're talking about to a higher level to brecht more people. the big question about boosters, semantics, called a booster or additional vaccine. a lot said two-dose vaccine like pfizer and moderna. not just one. correcting in that general correction but calling it a booster, two months or later after your first johnson & johnson vaccine. >> interesting. dr. john, a patient coming i had the j&j shot six, eight months ago, april-may, say. should i get moderna? get pfizer as a booster? what do you tell them? >> that's the information they're going over now. mixing and matching. data shows with one of the mrna vaccines on top of the j&j it it could give you more protection. this i

johnson & johnson's vaccine. >> reporter: yeah. the fda didn't make any direct authorization. but if you have been vaccinated with johnson& johnson and getting one of those mrna vaccines, the pfizer or moderna could increase your antibodies. >> thanks very much. i spoke to dr. anthony fauci about the vaccination plan for younger kids, and i wonder whether acting before the vaccinations are approved is somewhat presumptuous. >> i don't think it is presumptuous because we have made it clear that whatever happens will be dependent on the regulatory decision of the fda and the recommendations on the part of the cdc. we want to have the vaccine already distributed in pediatric offices, in pharmacies, in children's hospitals and in community centers. if we did not do that preparation, there would be a time lag in getting that vaccine to the children. >> let's talk about the resistance, defiance, whatever you want to call it to the current vaccines by adults what do you anticipate when it comes to giving shots to children, where people will lean? >> well, i hope they will be enthusiastic about it children of all ages do get inf

& johnson recipient to look for a pfizer or a moderna instead of johnson & johnsonthat's available to you. what the data is showing is particularly for johnson & johnson is getting one of the mrna vaccines mrna vaccines, pfizer or moderna, seems better than getting another johnson & johnson vaccine. if you're at a high risk or myocarditis, especially men, maybe getting a johnson & johnson is better for you. those are individual decisions. the data is showing that if you got johnson & johnson, getting that mrna vaccine, pfizer or moderna seems to be able to help you a little bit more. >> points well taken thank you so much. >>> they're small and powerful and in short supply. how that scarcity is creating a potential economic nightmare here in the u.s. and just being sustainable isn't enough. our future depends on regeneration. that's why we're working to not only protect our planet, but restore, renew, and replenish it. so we can all live better tomorrow. ♪♪ (burke) i've seen this movie before. (woman) you have? (burke) sure, this is the part where all is lost and th

johnson & johnson by november 14th. for christmas, your first moderna shot needs to be november 13th. for pfizer, november 30th and you have until december 11th for the johnson & johnson vaccine. there's a lot of numbers, a lot of information. so, you're going to need to look at that again and make it easy. we're tracking all the updates, changes and that timeline's on there for you as well. >> we may have nice weather ahead for the weekend. things are changing again. it seems like we're going to get at little rain and it's going to be warm again. >>> this is one of the more extreme u-turns in a weekend forecast than we've seen in a while. in san francisco, downtown urlier was closer to 80 degrees. 74 in san jose still at 80. so, the bottom line is if you like today, you'll love tomorrow. not much change for your saturday forecast. sunday is almost the opposite of saturday. going to trend cooler, more wind and clouds and a chance of seeing rain showers moving in. the long-range forecast looks like a big pattern shift ahead as you see a potential for heavy rain. some of the rain starting to arrive as early as sunday. we'll take a closer look at that timing an

johnson johnson. what's truly authorized is done. other johnson johnson either way, it's really important for johnson johnson people to get that second dose there's no doubt the all new to second. what happens if they do get a johnson and johnson because that's what's available or does it. >> it's we provide really good t cell immunity really could. what's called long term. we infection potential. there was billy great data from johnson johnson. 94% protection from hospitalizations with the second dose. so can't go wrong with getting. that is the second dose. if you want to wait to mix and match them. we have to get a couple weeks for it to be do you agree with doctor today who went on the record saying that the johnson and should have had a 2 dose vaccine. >> yes, i do agree with them, but i'm not sure we knew it before it was the reason they put it out as a one dose is they are hoping to help. >> resource limited settings, hoping to get more doses and people. but we don't actually have hardly any vaccines are one dose. yellow fever one example.

johnson & johnson data looks like this to us in our nonscientific minds. it looks like a lot of people agree a booster shot is needed but it looks like johnson & johnson's dataery good, and so if that's the issue, what do you do? >> well, actually, i think the concept of mixing and matching, chuck, looks very attractive to many of us. namely, al al though you've started with johnson & johnson, your second dose, which would be your booster could be either pfizer or moderna. and i think that study you just alluded to that they're going to be looking at this afternoon actually reinforces that. because the data showed that after that mix and match, you get a very large antibody rise. so that looks very attractive to many of us, and i think a lot of people out there who received johnson & johnson have heard about this. and are looking forward to it. >> i'm curious why -- why is it that these -- the mixing and matching is effective, considering these are -- if you told me that moderna and pfizer mixing and matching were effective, you'd be like okay, they're both mrna vaccines. why is mixing and matching this sort of viral vector vaccine with an mrna effective? >>

johnson & johnson vaccine really have not gotten any guidance at all. what this study found is that the people who got a second dose of johnson & johnson had a fourfold increaseery good. but people who got a second dose that's a pfizer vaccine had 35 times the level of neutralizing antibody increase and who got moderna, had a 76fold increase. and so, i think there are a lot of people who got the j&j vaccine who are now going to be wondering should i get the second dose that's something different than j&j? and again, i know that's something that the fda and cdc will be discussing in detail but this study certainly points in that direction. >> so you were part of the johnson & johnson vaccine trial. seeing this study, would you be getting or will you be getting a booster? and is it possible all those who received j&j could be eligible for one in the future, just simply based on those numbers? >> well, i think there have already been a lot of studies that have shown that people who got the johnson & johnson vaccine are not as well protected as those who got the pfizer and moderna vaccine. and so, i had already decided that i was going to get a booster. i have no

& johnson get the highest level of protection when boosted with moderna or pfizer. you were vaccinated with johnson & johnsonand you're eager for a booster. >> yes, we are i think that the extra layer of protection will make us feel more comfortable. >> reporter: with 9.5 million americans already boosted with pfizer, well over 30 million could soon qualify for an added shot of protection it comes just as infections and hospitalizations drop nationwide. >> it's depressing i wish everybody would get vaccinated. >> reporter: but in cold weather states where many are gathering and spreading the virus indoors, there are troubling signs of a rise in cases. tonight our nation hoping to fend off another surge while offering millions another dose of protection. >> and miguel joining us right now the cdc also mentioned they're keeping an eye on this so-called delta plus variant >> yeah. they're watching the number of cases here in the u.s they say they're not credibly alarming yet but definitely something to keep an eye on >> thanks very much. and potential warning signs of that variant coming from the u.k. tonight w

johnson & johnson. tal como lo hizo ayer la fda. >>> los reguladores de la fsda allanaron el camino para que mÁs personas puedan recibir tratamiento contra el covid-19. fue aprobada la vacuna de emergencia de moderna, y tambiÉn una dosis de refuerzo de johnson son las siguientes: (informaciÓn en pantalla) . >>> mayores de 65 aÑos para arriba, problemas de salud crÓnicos o defensas bajas, y personas que trabajan en horages que tienen mayores riesgos al enfermarse del virus. >>> los elegivies para una dosis de johnson & johnson son los mayores de 18 aÑos. personas que consultamos ven con buenos ojos la protecciÓn adicional. >>> me la voy a poner con gusto. >>> cuÁl se puso usted? >>> donerma. >>> es una buena opciÓn. >>> la posibilidad de mezclar las vacunas distintas a las usadas en el inicio segÚn la fda es seguro y efectivo. . >>> si las mezclas, el resultado va a llegar. >>> y precisamente sobre este tema es la pregunta de toy jueves. estarÍa de acuerdo con vacunarse con una dosis distinta de la que ya recibiÓ inicialmente? comparta sus opiniones visitando nuestras redes sociales. (informaciÓn en pantalla) vamos a una pausa. al regresar. estaremos ncpr en do sobre la alerta para quienes trabajan en el campo o construcciÓn porque estÁn en

that johnson & johnson is not as effective as the other vaccines and it needs moderna to make it work as a booster? >> if it were not for the fact that the mrna vaccines were so fantastic johnson it be correct right now because they still have a good vaccine that is saved a lot of lives. it is a vaccine that works with windows and something that does not require the kind of gold chain that would make it difficult to distribute in places like south sudan, so i have i hopes the johnson & johnson vaccine will be a mainstay of what we need to do for the world. it is still a very good vaccine. anchor: dr. collins, thank you so much for being with us. >> like to join you. anchor: in no way a bow and arrow attack as left five people dead, and the police are treating the incident as terrorism. suspect is being held after a man went on the rampage last night. our corresponnt is there and sent this report. corrpondent: a medieval weapon of modern terror piercing the comn of this one sleepy town. police were called after 6:00 last night when an attacker fired indiscriminately from his w and arrow. when they tried to intervene he unleashed more volleys. by the time they got him 30 minutes

both the johnson & johnson boost or mrna boost. >> and the johnson & johnson, that's a one dose shot,>> at least two months, but it can be six months later. i think, frankly, in retrospect johnson & johnson's was probably always a two-dose vaccine. when we reviewed those data in february, they were in the midst of a two-dose trial which they finished a few months after that and clearly showed there the efficacy was 94% as compared to 75% against illness with the one dose vaccine. so i think that is a two-dose vaccine. >> dr. paul offit, as usual, thank you very, very much. >>> coming up, former trump strategist steve bannon now in contempt of the u.s. congress. we'll take a closer look at the unusual path that brought him to this point. or lines for family members, you'll get great value on america's most reliable 5g network. like 2 lines of unlimited for just $27.50 a line. only at t-mobile. this wasn't an old bear, it was like a bear squatch. dad, what's a bear squatch? it's a cross between a bear and a sas... it's made up. -he's usually sleeping. -he'll never sleep again. experienc

& johnson, any over 18 years old is eligible for a booster shot. >> so doctor, the booster shot for johnson & johnson, first of all, it should be two months after receiving that johnson & johnson shot, right? which is very unusual. the other ones were saying six months or more. so if i got the j&j vaccine, right, and that was after -- you know, much after two months ago -- >> months ago. >> where do i go get it? what booster do i get? >> right. and so that's the issue. the fda has not given any clear guidance on which vaccine -- and the reason why is because there's really not enough data yet. we have preliminary data showing that if you mix and match the johnson & johnson with mrna vaccine, you get a higher antibody response. but we know that the immune system is more complicates than that. so essentially they're saying, you can get any booster. if you received johnson & johnson, you can go to get your nearest vaccine site or pharmacy and get another johnson & johnson or an mrna vaccine. we know it's safe and effective to get a booster shot. i think we'll get more data over time as to which mix and

johnson & johnson. ahora más información. >>> a quien el condado de santa clara ya estamos administrando la vacuna de refuerzo y no solo de la farmacéutica pfizer sino que también moderna y johnson son recomendadas para todas aquellas personas que recibieron la vacuna de johnson & johnson y que tienen dieciocho años y que la recibieron hace menos de dos meses. >>> en el caso de las personas que se han postró tras vacunas. >>> a que se personas que han recibido otras vacunas a la segunda dosis de la vacuna moderna también tienen que haber pasado al menos seis meses desde que han recibido la segundo dosis y tener más de dieciocho años, es en estos momentos recomendable para aquellas personas que tienen sesenta y cinco años o más o quienes tienen cincuenta años y tienen alguna condición médica o también para aquellas personas que tienen dieciocho años o tiene más de dieciocho años y viven o trabajan en un lugar donde se encuentran expuestos ante el covid-19. >>> quien recibiera la vacuna de johnson & johnson hace unos meses pueda ahora reforzarla con una vacuna de moderna o pfizer, por su parte las farmacias (nombre/s en inglés) ya han dicho que se encuentran ofreciendo la vacuna d

& johnson. >> la fda (food and drug administration) di ten la dosis de refuerzo de johnson & johnsona que mezcla contra covid-19 es segura y efectiva ayer el mismo grupo recomendÓ la segunda dosis de moderna para personas con alto riesgo de desarrollar una forma grave de la enfermedad o quienes por su trabajo o situaciones de vida corren mayor riesgo de contraer el virus. >> hay un estudio que es el estudio en moderna donde 14 mil personas se evaluaron y estas personas tenÍan 36% menos riesgo de tener infecciones. >> la determinaciÓn final acerca de las dosis de refuerzo de johnson & johnson y moderna la tomarÁ la prÓxima semana un panel de los centros para el control y prevenciÓn de enfermedades por otra parte nueva york estÁ llevando su vacuna a 6 cines con puestos mÓviles, puestos a esos establecimientos el alcalde de nueva york, bill de blasio dijo que se estarÁ ofreciendo 100 dÓlares para los que se pongan la primera dosis. >> los puestos de vacunaciÓn comienzan a operar este fin de semana, cabe anotar que estos establecimientos forman parte del mandato de la vacuna, es decir to

& johnson vaccine had a lower efficacy rate, about 72% versus moderna or pfizer, which are around 94, 95%. and with a booster shot, now, the johnson & johnson efficacy is now 100% reportedly, so then why not in the first place get the two doses of johnson & johnson? >> so, fred, i think when the vaccines were first released, the united states, we were essentially hemorrhaging, we were at a point that we had never seen before, seeing 3, 4,000 deaths per day. upwards of 200,000 kcases per day, and we needed to get our population protected and so our vaccines were released in order to try to prevent people from dieing and prevent hospitalizations. the johnson & johnson vaccine while it may have had lower efficacy in contracting covid illness, it was still very effective against hospitalizations and deaths, so it was right to release the vaccine at that point, but now we have more information and so our recommendations have changed. >> and so you don't have a problem with the fact that it was sold as a one shot wonder with a lower efficacy. you think it was still important to have that out there and you like the idea even more now that the effi

johnson & johnson's vaccine for anyone 18 and older at least two months after the initial dose regulators did not see any evidence of serious safety concerns, but noted they weren't given enough time to independently review much of j&j's data. >> we are seeing that people who receive the johnson & johnson vaccine have a slightly higher risk of severe disease, hospitalization and death versus people who got the pfizer and moderna vaccines so i do think an additional dose is warranted for people who got one dose of the johnson & johnson vaccine. >> reporter: the vote comes after the panel unanimously recommended the use of a half dose moderna booster for many americans yesterday. the fda itself typically follows the panel's advice and is expected to rule on both boosters within days before the cdc would sign on. a confusing process for many americans because it usually plays out away from the spotlight. >> i think this is an unprecedented, historic situation that the american public is so intimately aware of. >> reporter: the panel also discussed whether it is okay to mix and match vaccines for example, getting a moderna booster if you got a j&j initial dose the advisers haven't yet voted on a position, but indicated there is a robust antibody response, no matter which booster

johnson shots. the agency is expected to say that mixing and matching is safe. for example, a person vaccinated with johnson & johnson could get the pfizer or moderna vaccine as a booster. infectious disease dr. monica gandhi says it's good news. it doesn't just protect you against hospitalization but even infection or having any symptoms at all. >> exactly, yes, there was an improved protection from any symptomatic infection. >> reporter: getting covid after being fully vaccinated remains rare, but colin powell's death from covid this week brought the immunocompromised and elderly into focus. powell was 84 years old and also had parkinson's and multiple myeloma. >> that's one of the reasons why back in august a recommendation from the fda and then cdc came to get that third immunization in those who are immunocompromised in the hopes he w older, he had multiple eloma.hrgh hoslizati or a breakthrough death, unfortunately it's someone like the general. >> reporter: in one of his last interviews, powell told reporter bob woodward -- >> don't feel for sorry me. for god's sakes. i haven't lost a day of life fighting thes